Transaction in Own Shares • May 26, 2015
Transaction in Own Shares
Open in ViewerOpens in native device viewer
May 26, 2015
As of May 22, Novozymes has purchased an accumulated 2,341,569 shares with a transaction value of DKK 745.3 million under the stock buyback program Novozymes announced in Company announcement No. 6, 2015 and initiated February 2, 2015. Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2015.
The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:
| Number of shares | Average purchase price | Transaction value, DKK | |
|---|---|---|---|
| Accumulated, last announcement | 2,228,109 | 709,576,492 | |
| 18 May 2015 | 25,000 | 311.51 | 7,787,641 |
| 19 May 2015 | 21,500 | 314.24 | 6,756,157 |
| 20 May 2015 | 14,540 | 315.81 | 4,591,884 |
| 21 May 2015 | 22,420 | 316.81 | 7,102,770 |
| 22 May 2015 | 30,000 | 317.31 | 9,519,273 |
| Accumulated under the program | 2,341,569 | 745,334,217 |
In addition, transactions necessitated by Novozymes' previously established incentive programs have resulted in a net sale by Novozymes of 14,270 B shares in the period from May 18 to May 22, 2015. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
Following the transactions stated above, Novozymes owns a total of 6,242,536 treasury shares, corresponding to 2.0% of the stock capital. The total number of shares in the company is 313,000,000 including treasury shares.
| Investor Relations: | ||
|---|---|---|
| Thomas Bomhoff (DK) | +45 3077 1226 | [email protected] |
| Klaus Sindahl (DK) | +45 5363 0134 | [email protected] |
| Martin Riise (USA) | +1 919 649 2565 | [email protected] |
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping to build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com NASDAQ OMX: NZYM-B ● 6,500 employees ● 12B DKK turnover ● 30+ industries ● 700+ products
Krogshoejvej 36 2880 Bagsvaerd Denmark
Telephone: +45 4446 0000 Email: [email protected] Internet: www.novozymes.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.